Matti A Rookus

Summary

Affiliation: The Netherlands Cancer Institute
Country: The Netherlands

Publications

  1. pmc No efficacy of annual gynaecological screening in BRCA1/2 mutation carriers; an observational follow-up study
    B B J Hermsen
    Department of Obstetrics and Gynaecology, VU University Medical Centre, Amsterdam, The Netherlands
    Br J Cancer 96:1335-42. 2007
  2. pmc The Nightingale study: rationale, study design and baseline characteristics of a prospective cohort study on shift work and breast cancer risk among nurses
    Anouk Pijpe
    Netherlands Cancer Institute, Department of Epidemiology, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands
    BMC Cancer 14:47. 2014
  3. pmc Common breast cancer susceptibility alleles are associated with tumour subtypes in BRCA1 and BRCA2 mutation carriers: results from the Consortium of Investigators of Modifiers of BRCA1/2
    Anna Marie Mulligan
    Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, 2 Worts Causeway, Cambridge, CB1 8RN, UK
    Breast Cancer Res 13:R110. 2011
  4. pmc Exploring the link between MORF4L1 and risk of breast cancer
    Griselda Martrat
    Translational Research Laboratory, Catalan Institute of Oncology, Bellvitge Institute for Biomedical Research IDIBELL, Gran Via 199, L Hospitalet del Llobregat 08908, Spain
    Breast Cancer Res 13:R40. 2011
  5. doi request reprint Physical activity and the risk of breast cancer in BRCA1/2 mutation carriers
    Anouk Pijpe
    Department of Epidemiology, Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands
    Breast Cancer Res Treat 120:235-44. 2010
  6. doi request reprint Body weight and risk of breast cancer in BRCA1/2 mutation carriers
    Peggy Manders
    Department of Epidemiology, Netherlands Cancer Institute, Amsterdam, The Netherlands
    Breast Cancer Res Treat 126:193-202. 2011
  7. doi request reprint No effect of red clover-derived isoflavone intervention on the insulin-like growth factor system in women at increased risk of colorectal cancer
    Alina Vrieling
    Division of Experimental Therapy, The Netherlands Cancer Institute, Amsterdam, The Netherlands
    Cancer Epidemiol Biomarkers Prev 17:2585-93. 2008
  8. doi request reprint Validation study suggested no differential misclassification of self-reported mammography history in BRCA1/2 mutation carriers
    Anouk Pijpe
    Department of Epidemiology, Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands
    J Clin Epidemiol 64:1434-43. 2011
  9. pmc Exposure to diagnostic radiation and risk of breast cancer among carriers of BRCA1/2 mutations: retrospective cohort study (GENE-RAD-RISK)
    Anouk Pijpe
    Netherlands Cancer Institute, Department of Epidemiology and Biostatistics, Plesmanlaan 121, 1066 CX Amsterdam, Netherlands
    BMJ 345:e5660. 2012
  10. doi request reprint Breast and ovarian cancer risks in a large series of clinically ascertained families with a high proportion of BRCA1 and BRCA2 Dutch founder mutations
    Richard M Brohet
    Department of Epidemiology and Pathology, The Netherlands Cancer Institute, Amsterdam, The Netherlands
    J Med Genet 51:98-107. 2014

Collaborators

Detail Information

Publications16

  1. pmc No efficacy of annual gynaecological screening in BRCA1/2 mutation carriers; an observational follow-up study
    B B J Hermsen
    Department of Obstetrics and Gynaecology, VU University Medical Centre, Amsterdam, The Netherlands
    Br J Cancer 96:1335-42. 2007
    ..Therefore, it is unlikely that annual screening will reduce mortality from ovarian cancer in BRCA1/2 mutation carriers...
  2. pmc The Nightingale study: rationale, study design and baseline characteristics of a prospective cohort study on shift work and breast cancer risk among nurses
    Anouk Pijpe
    Netherlands Cancer Institute, Department of Epidemiology, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands
    BMC Cancer 14:47. 2014
    ..The study design, methods, and baseline characteristics of the cohort are described...
  3. pmc Common breast cancer susceptibility alleles are associated with tumour subtypes in BRCA1 and BRCA2 mutation carriers: results from the Consortium of Investigators of Modifiers of BRCA1/2
    Anna Marie Mulligan
    Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, 2 Worts Causeway, Cambridge, CB1 8RN, UK
    Breast Cancer Res 13:R110. 2011
    ..It is currently unknown how these alleles are associated with different breast cancer subtypes in BRCA1 and BRCA2 mutation carriers defined by estrogen (ER) or progesterone receptor (PR) status of the tumour...
  4. pmc Exploring the link between MORF4L1 and risk of breast cancer
    Griselda Martrat
    Translational Research Laboratory, Catalan Institute of Oncology, Bellvitge Institute for Biomedical Research IDIBELL, Gran Via 199, L Hospitalet del Llobregat 08908, Spain
    Breast Cancer Res 13:R40. 2011
    ..To gain deeper insight into this pathway and its influence on cancer risk, we searched for novel components through protein physical interaction screens...
  5. doi request reprint Physical activity and the risk of breast cancer in BRCA1/2 mutation carriers
    Anouk Pijpe
    Department of Epidemiology, Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands
    Breast Cancer Res Treat 120:235-44. 2010
    ..Engaging in sports activity after age 30 was also inversely associated with breast cancer risk (HR = 0.63, 95%CI = 0.44-0.91). Our results indicate that sports activity may reduce the risk of breast cancer in BRCA1/2 mutation carriers...
  6. doi request reprint Body weight and risk of breast cancer in BRCA1/2 mutation carriers
    Peggy Manders
    Department of Epidemiology, Netherlands Cancer Institute, Amsterdam, The Netherlands
    Breast Cancer Res Treat 126:193-202. 2011
    ..Carriers may reduce their risk of postmenopausal breast cancer by maintaining a healthy body weight throughout life...
  7. doi request reprint No effect of red clover-derived isoflavone intervention on the insulin-like growth factor system in women at increased risk of colorectal cancer
    Alina Vrieling
    Division of Experimental Therapy, The Netherlands Cancer Institute, Amsterdam, The Netherlands
    Cancer Epidemiol Biomarkers Prev 17:2585-93. 2008
    ..The aim of the study was to investigate the effect of isolated isoflavones on serum concentrations of IGF system components...
  8. doi request reprint Validation study suggested no differential misclassification of self-reported mammography history in BRCA1/2 mutation carriers
    Anouk Pijpe
    Department of Epidemiology, Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands
    J Clin Epidemiol 64:1434-43. 2011
    ..We assessed accuracy of self-reported lifetime mammography history by BRCA1/2 mutation carriers with and without breast cancer...
  9. pmc Exposure to diagnostic radiation and risk of breast cancer among carriers of BRCA1/2 mutations: retrospective cohort study (GENE-RAD-RISK)
    Anouk Pijpe
    Netherlands Cancer Institute, Department of Epidemiology and Biostatistics, Plesmanlaan 121, 1066 CX Amsterdam, Netherlands
    BMJ 345:e5660. 2012
    ..To estimate the risk of breast cancer associated with diagnostic radiation in carriers of BRCA1/2 mutations...
  10. doi request reprint Breast and ovarian cancer risks in a large series of clinically ascertained families with a high proportion of BRCA1 and BRCA2 Dutch founder mutations
    Richard M Brohet
    Department of Epidemiology and Pathology, The Netherlands Cancer Institute, Amsterdam, The Netherlands
    J Med Genet 51:98-107. 2014
    ..BRCA1 or BRCA2 mutations confer increased risks of breast and ovarian cancer, but risks have been found to vary across studies and populations...
  11. doi request reprint Reliability of self-reported diagnostic radiation history in BRCA1/2 mutation carriers
    Anouk Pijpe
    Department of Epidemiology, Netherlands Cancer Institute, Plesmanlaan 121, Amsterdam, The Netherlands
    Eur J Epidemiol 25:103-13. 2010
    ..More consistent reporting was mainly determined by a younger age at questionnaire completion. In conclusion, inconsistent self-report of diagnostic radiation by BRCA1/2 mutation carriers was mainly non-differential by disease status...
  12. ncbi request reprint TP53 germline mutation testing in 180 families suspected of Li-Fraumeni syndrome: mutation detection rate and relative frequency of cancers in different familial phenotypes
    Marielle W G Ruijs
    Family Cancer Clinic, The Netherlands Cancer Institute, Amsterdam, The Netherlands
    J Med Genet 47:421-8. 2010
    ..In addition to the risk for established LFS tumour types, TP53-positive individuals may also have an elevated risk for pancreatic and colon cancer...
  13. doi request reprint Estradiol and testosterone levels are lower after oophorectomy than after natural menopause
    Catharina M Korse
    Department of Clinical Chemistry, The Netherlands Cancer Institute Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands
    Tumour Biol 30:37-42. 2009
    ..The aim of this study was to compare hormone levels between women who became postmenopausal after a prophylactic bilateral salpingo-oophorectomy, and women who became postmenopausal in a natural way...
  14. pmc Cancer risk in DES daughters
    Janneke Verloop
    Department of Epidemiology, Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands
    Cancer Causes Control 21:999-1007. 2010
    ..We examined long-term risk of cancer in women exposed to diethylstilbestrol (DES) in utero...
  15. ncbi request reprint Oral contraceptives and breast cancer risk in the international BRCA1/2 carrier cohort study: a report from EMBRACE, GENEPSO, GEO-HEBON, and the IBCCS Collaborating Group
    Richard M Brohet
    Netherlands Cancer Institute, Department of Epidemiology, Amsterdam, The Netherlands
    J Clin Oncol 25:3831-6. 2007
    ..However, duration of use, especially before first full-term pregnancy, may be associated with an increasing risk of breast cancer among both BRCA1 and BRCA2 mutation carriers...
  16. doi request reprint Effects of lycopene on the insulin-like growth factor (IGF) system in premenopausal breast cancer survivors and women at high familial breast cancer risk
    Dorien W Voskuil
    Division of Experimental Therapy and the Department of Epidemiology, The Netherlands Cancer Institute, Amsterdam, The Netherlands
    Nutr Cancer 60:342-53. 2008
    ..However, lycopene effects were discordant between the 2 study populations showing beneficial effects in high-risk healthy women but not in breast cancer survivors...